Department of Internal Medicine I, University Hospital of Ulm, Ulm, Germany.
Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Front Immunol. 2023 Sep 11;14:1231274. doi: 10.3389/fimmu.2023.1231274. eCollection 2023.
A multitude of alterations in the old immune system impair its functional integrity. Closely related, older individuals show, for example, a reduced responsiveness to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines. However, systematic strategies to specifically improve the efficacy of vaccines in the old are missing or limited to simple approaches like increasing the antigen concentration or injection frequencies. We here asked whether the intrinsic, trimeric structure of the SARS-CoV-2 spike (S) antigen and/or a DNA- or protein-based antigen delivery platform affects priming of functional antibody responses particularly in old mice. The used S-antigens were primarily defined by the presence/absence of the membrane-anchoring TM domain and the closely interlinked formation/non-formation of a trimeric structure of the receptor binding domain (S-RBD). Among others, we generated vectors expressing prefusion-stabilized, cell-associated (TM) trimeric "S2-P" or secreted (TM) monomeric "S6-P" antigens. These proteins were produced from vector-transfected HEK-293T cells under mild conditions by Strep-tag purification, revealing that cell-associated but not secreted S proteins tightly bound Hsp73 and Grp78 chaperones. We showed that both, TM-deficient S6-P and full-length S2-P antigens elicited very similar S-RBD-specific antibody titers and pseudovirus neutralization activities in young (2-3 months) mice through homologous DNA-prime/DNA-boost or protein-prime/protein-boost vaccination. The trimeric S2-P antigen induced high S-RBD-specific antibody responses in old (23-24 months) mice through DNA-prime/DNA-boost vaccination. Unexpectedly, the monomeric S6-P antigen induced very low S-RBD-specific antibody titers in old mice through homologous DNA-prime/DNA-boost or protein-prime/protein-boost vaccination. However, old mice efficiently elicited an S-RBD-specific antibody response after heterologous DNA-prime/protein-boost immunization with the S6-P antigen, and antibody titers even reached similar levels and neutralizing activities as in young mice and also cross-reacted with different S-variants of concern. The old immune system thus distinguished between trimeric and monomeric S protein conformations: it remained antigen responsive to the trimeric S2-P antigen, and a simple change in the vaccine delivery regimen was sufficient to unleash its reactivity to the monomeric S6-P antigen. This clearly shows that both the antigen structure and the delivery platform are crucial to efficiently prime humoral immune responses in old mice and might be relevant for designing "age-adapted" vaccine strategies.
衰老的免疫系统发生了大量改变,使其功能完整性受损。密切相关的是,老年人对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)疫苗的反应性降低。然而,特异性提高老年人疫苗效果的系统策略要么缺失,要么仅限于增加抗原浓度或注射频率等简单方法。我们在这里想知道,SARS-CoV-2 刺突(S)抗原的固有三聚体结构和/或基于 DNA 或蛋白质的抗原递呈平台是否会影响功能抗体反应的产生,特别是在老年小鼠中。使用的 S 抗原主要通过存在/不存在膜锚定 TM 结构域和受体结合域(S-RBD)的三聚体结构的紧密连接形成/不形成来定义。除其他外,我们生成了表达融合前稳定的、细胞相关(TM)三聚体“S2-P”或分泌(TM)单体“S6-P”抗原的载体。这些蛋白通过 Strep 标签纯化,在温和条件下从转染的 HEK-293T 细胞中产生,表明细胞相关但不分泌的 S 蛋白与 Hsp73 和 Grp78 伴侣紧密结合。我们表明,缺失 TM 的 S6-P 和全长 S2-P 抗原在年轻(2-3 个月)小鼠中通过同源 DNA 初免/DNA 加强或蛋白初免/蛋白加强免疫接种,均可引发非常相似的 S-RBD 特异性抗体滴度和假病毒中和活性。通过 DNA 初免/DNA 加强免疫接种,三聚体 S2-P 抗原在老年(23-24 个月)小鼠中诱导高 S-RBD 特异性抗体反应。出乎意料的是,通过同源 DNA 初免/DNA 加强或蛋白初免/蛋白加强免疫接种,单体 S6-P 抗原在老年小鼠中仅诱导非常低的 S-RBD 特异性抗体滴度。然而,老年小鼠通过 S6-P 抗原的异源 DNA 初免/蛋白加强免疫接种,有效地引发了 S-RBD 特异性抗体反应,抗体滴度甚至达到与年轻小鼠相似的水平和中和活性,并且也与不同的关注 S 变体发生交叉反应。衰老的免疫系统因此区分了三聚体和单体 S 蛋白构象:它仍然对三聚体 S2-P 抗原有反应性,疫苗给药方案的简单改变足以激发其对单体 S6-P 抗原的反应性。这清楚地表明,抗原结构和递呈平台对于在老年小鼠中有效引发体液免疫反应都至关重要,并且可能与设计“适应年龄”的疫苗策略相关。